Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Akshay N Gupte

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
Open Forum Infectious Diseases|January 31, 2022
Increased Moxifloxacin Dosing Among Patients With Multidrug-Resistant Tuberculosis With Low-Level Resistance to Moxifloxacin Did Not Improve Treatment Outcomes in a Tertiary Care Center in Mumbai, IndiaJeffrey A Tornheim, Zarir F Udwadia, Prerna R Arora, et al.
Scientific Reports|May 12, 2023
A multi-center, prospective cohort study of whole blood gene expression in the tuberculosis-diabetes interactionArtur T L Queiroz, Caian L Vinhaes, Eduardo R Fukutani, et al.
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|November 4, 2019
MAL adaptor (TIRAP) S180L polymorphism and severity of disease among tuberculosis patientsRajagopalan Saranathan, Pattabiraman Sathyamurthi, Kannan Thiruvengadam, et al.
Annals of the American Thoracic Society|December 1, 2023
Early Microbiologic Markers of Pulmonary Tuberculosis Treatment OutcomesMandar Sudhir Paradkar, Neeta Nitin Pradhan, Subramanyam Balaji, et al.
The Journal of Infectious Diseases|December 5, 2019
Transcriptomic Profiles of Confirmed Pediatric Tuberculosis Patients and Household Contacts Identifies Active Tuberculosis, Infection, and Treatment Response Among Indian ChildrenJeffrey A Tornheim, Anil K Madugundu, Mandar Paradkar, et al.
Iscience|January 11, 2024
The sound of silent RNA in tuberculosis and the lncRNA role on infectionEduardo Fukutani Rocha, Caian Leal Vinhaes, Mariana Araújo-Pereira, et al.
Plos One|August 1, 2019
Smoking, alcohol use disorder and tuberculosis treatment outcomes: A dual co-morbidity burden that cannot be ignoredBeena Elizabeth Thomas, Kannan Thiruvengadam, Rani S, et al.
Plos One|November 2, 2019
Correction: Smoking, alcohol use disorder and tuberculosis treatment outcomes: A dual co-morbidity burden that cannot be ignoredBeena Elizabeth Thomas, Kannan Thiruvengadam, Rani S, et al.
The European Respiratory Journal|October 29, 2021
Baseline IL-6 is a biomarker for unfavourable tuberculosis treatment outcomes: a multisite discovery and validation studyAkshay N Gupte, Pavan Kumar, Mariana Araújo-Pereira, et al.
Plos One|December 6, 2019
Correction: Assessment of lung function in successfully treated tuberculosis reveals high burden of ventilatory defects and COPDAkshay N Gupte, Mandar Paradkar, Sriram Selvaraju, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Open Forum Infectious Diseases|January 31, 2022
Increased Moxifloxacin Dosing Among Patients With Multidrug-Resistant Tuberculosis With Low-Level Resistance to Moxifloxacin Did Not Improve Treatment Outcomes in a Tertiary Care Center in Mumbai, IndiaJeffrey A Tornheim, Zarir F Udwadia, Prerna R Arora, et al.
Scientific Reports|May 12, 2023
A multi-center, prospective cohort study of whole blood gene expression in the tuberculosis-diabetes interactionArtur T L Queiroz, Caian L Vinhaes, Eduardo R Fukutani, et al.
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|November 4, 2019
MAL adaptor (TIRAP) S180L polymorphism and severity of disease among tuberculosis patientsRajagopalan Saranathan, Pattabiraman Sathyamurthi, Kannan Thiruvengadam, et al.
Annals of the American Thoracic Society|December 1, 2023
Early Microbiologic Markers of Pulmonary Tuberculosis Treatment OutcomesMandar Sudhir Paradkar, Neeta Nitin Pradhan, Subramanyam Balaji, et al.
The Journal of Infectious Diseases|December 5, 2019
Transcriptomic Profiles of Confirmed Pediatric Tuberculosis Patients and Household Contacts Identifies Active Tuberculosis, Infection, and Treatment Response Among Indian ChildrenJeffrey A Tornheim, Anil K Madugundu, Mandar Paradkar, et al.
Iscience|January 11, 2024
The sound of silent RNA in tuberculosis and the lncRNA role on infectionEduardo Fukutani Rocha, Caian Leal Vinhaes, Mariana Araújo-Pereira, et al.
Plos One|August 1, 2019
Smoking, alcohol use disorder and tuberculosis treatment outcomes: A dual co-morbidity burden that cannot be ignoredBeena Elizabeth Thomas, Kannan Thiruvengadam, Rani S, et al.
Plos One|November 2, 2019
Correction: Smoking, alcohol use disorder and tuberculosis treatment outcomes: A dual co-morbidity burden that cannot be ignoredBeena Elizabeth Thomas, Kannan Thiruvengadam, Rani S, et al.
The European Respiratory Journal|October 29, 2021
Baseline IL-6 is a biomarker for unfavourable tuberculosis treatment outcomes: a multisite discovery and validation studyAkshay N Gupte, Pavan Kumar, Mariana Araújo-Pereira, et al.
Plos One|December 6, 2019
Correction: Assessment of lung function in successfully treated tuberculosis reveals high burden of ventilatory defects and COPDAkshay N Gupte, Mandar Paradkar, Sriram Selvaraju, et al.
Pageof 3